Precise immunological evaluation rationalizes the design of a self-adjuvanting vaccine composed of glycan antigen, TLR1/2 ligand, and T-helper cell epitope

Tsung-Che Chang, Yoshiyuki Manabe, Keita Ito, Ryuku Yamamoto, Kazuya Kabayama, Shino Ohshima, Yoshie Kametani, Yukari Fujimoto, Chun-Cheng Lin and Koichi Fukase

RSC Adv., 2022, 12, 18985
DOI: 10.1039/D2RA03286D

Enhancing T cell responses and tumour immunity by vaccination with peptides conjugated to a weak NKT cell agonist

Benjamin J. Compton, Kathryn J. Farrand, Ching-wen Tang, Taryn L. Osmond, Mary Speir, Astrid Authier-Hall, Jing Wang, Peter M. Ferguson, Susanna T. S. Chan, Regan J. Anderson, Taylor R. Cooney, Colin M. Hayman, Geoffrey M. Williams, Margaret A Brimble, Collin R. Brooks, Lin-Kin Yong, Leonid S. Metelitsa, Dirk M. Zajonc, Dale I. Godfrey, Olivier Gasser, Robert Weinkove, Gavin F. Painter and Ian F. Hermans

Org. Biomol. Chem., 2019, 17, 1225
DOI: 10.1039/C8OB02982B

From the banal to the bizarre: unravelling immune recognition and response to microbial lipids

Laura Burchill and Spencer J. Williams

Chem. Commun., 2022, 58, 925
DOI: 10.1039/D1CC06003A

Expanding the biomass derived chemical space

Nicolas Brun, Peter Hesemann and Davide Esposito

Chem. Sci., 2017, 8, 4724
DOI: 10.1039/C7SC00936D

Synthetic preparation and immunological evaluation of β-mannosylceramide and related N-acyl analogues

Sage A. Robinson, Jessica Yau, Masaki Terabe, Jay A. Berzofsky, Gavin F. Painter, Benjamin J. Compton and David S. Larsen

Org. Biomol. Chem., 2020, 18, 2739
DOI: 10.1039/D0OB00223B

Synthesis and immunological evaluation of TLR1/2 ligand-conjugated RBDs as self-adjuvanting vaccine candidates against SARS-CoV-2

Yoshiyuki Manabe, Brandon Gárate-Reyes, Keita Ito, Ramón Hurtado-Guerrero, Kazuya Kabayama and Koichi Fukase

Chem. Commun., 2024, 60, 3946
DOI: 10.1039/D4CC00462K

Recent progress in synthetic self-adjuvanting vaccine development

Daryl Ariawan, Janet van Eersel, Adam D. Martin, Yazi D. Ke and Lars M. Ittner

Biomater. Sci., 2022, 10, 4037
DOI: 10.1039/D2BM00061J

6″-Modifed α-GalCer-peptide conjugate vaccine candidates protect against liver-stage malaria

Michael A. Meijlink, Yu Cheng Chua, Susanna T. S. Chan, Regan J. Anderson, Matthew W. Rosenberg, Anton Cozijnsen, Vanessa Mollard, Geoffrey I. McFadden, Sarah L. Draper, Lauren E. Holz, Ian F. Hermans, William R. Heath, Gavin F. Painter and Benjamin J. Compton

RSC Chem. Biol., 2022, 3, 551
DOI: 10.1039/D1CB00251A

Recent advances in self-adjuvanting glycoconjugate vaccines

Yoshiyuki Manabe, Tsung-Che Chang and Koichi Fukase

Drug Discovery Today: Technologies, 2020, 37, 61
DOI: 10.1016/j.ddtec.2020.11.006

Recruiting Natural Killer T Cells to Improve Vaccination: Lessons from Preclinical and Clinical Studies

Olivia K. Burn, Nathaniel Dasyam and Ian F. Hermans

Crit Rev Oncog, 2024, 29, 31
DOI: 10.1615/CritRevOncog.2023049407

Using agonists for iNKT cells in cancer therapy

Gavin F. Painter, Olivia K. Burn and Ian F. Hermans

Molecular Immunology, 2021, 130, 1
DOI: 10.1016/j.molimm.2020.12.010

An Efficient and Concise Synthesis of α-Galactosylceramide

Daniela Imperio, Laura Morelli, Federica Compostella and Luigi Panza

Synlett, 2021, 32, 287
DOI: 10.1055/a-1293-9578

Synthesis and Biological Evaluation of Peptide-Adjuvant Conjugate Vaccines with Increasing Antigen Content

Taylor R. Cooney, Kathryn Farrand, Sarah L. Draper, Regan J. Anderson, Phillip M. Rendle, Ian F. Hermans, Benjamin J. Compton and Gavin F. Painter

Bioconjugate Chem., 2023
DOI: 10.1021/acs.bioconjchem.3c00106

Programmable Antigen‐Specific Immunity via Self‐Adjuvanting Nanovaccines Co‐Delivering Immune Modulators

Keita Ito, Yoshiyuki Manabe, Shino Ohshima, Masatoshi Maeki, Manabu Tokeshi, Hiroshi Inaba, Kazunori Matsuura, Kazuya Kabayama, Yoshie Kametani and Koichi Fukase

Angew Chem Int Ed, 2026, 65
DOI: 10.1002/anie.202520474

The Conventional Nature of Non-MHC-Restricted T Cells

Marco Lepore, Lucia Mori and Gennaro De Libero

Front. Immunol., 2018, 9
DOI: 10.3389/fimmu.2018.01365

Fully Synthetic Invariant NKT Cell-Dependent Self-Adjuvanting Antitumor Vaccines Eliciting Potent Immune Response in Mice

Pu-Guang Chen, Hong-Guo Hu, Zhan-Yi Sun, Qian-Qian Li, Bo-Dou Zhang, Jun-Jun Wu, Wen-Hao Li, Yu-Fen Zhao, Yong-Xiang Chen and Yan-Mei Li

Mol. Pharmaceutics, 2019
DOI: 10.1021/acs.molpharmaceut.9b00720

Immunomodulatory glycomedicine: Introducing next generation cancer glycovaccines

Rui Freitas, Andreia Peixoto, Eduardo Ferreira, Andreia Miranda, Lúcio Lara Santos and José Alexandre Ferreira

Biotechnology Advances, 2023, 65, 108144
DOI: 10.1016/j.biotechadv.2023.108144

Natural and synthetic carbohydrate-based vaccine adjuvants and their mechanisms of action

Carlo Pifferi, Roberto Fuentes and Alberto Fernández-Tejada

Nat Rev Chem, 2021, 5, 197
DOI: 10.1038/s41570-020-00244-3

Augmenting Influenza-Specific T Cell Memory Generation with a Natural Killer T Cell-Dependent Glycolipid–Peptide Vaccine

Regan J. Anderson, Jasmine Li, Lukasz Kedzierski, Benjamin J. Compton, Colin M. Hayman, Taryn L. Osmond, Ching-wen Tang, Kathryn J. Farrand, Hui-Fern Koay, Catarina Filipa Dos Santos Sa E. Almeida, Lauren R. Holz, Geoffrey M. Williams, Margaret A Brimble, Zhongfang Wang, Marios Koutsakos, Katherine Kedzierska, Dale I. Godfrey, Ian F. Hermans, Stephen J. Turner and Gavin F. Painter

ACS Chem. Biol., 2017, 12, 2898
DOI: 10.1021/acschembio.7b00845

Unconventional T Cell Targets for Cancer Immunotherapy

Dale I. Godfrey, Jérôme Le Nours, Daniel M. Andrews, Adam P. Uldrich and Jamie Rossjohn

Immunity, 2018, 48, 453
DOI: 10.1016/j.immuni.2018.03.009

Stereoselective Synthesis of Sialyl Lewisa Antigen and the Effective Anticancer Activity of Its Bacteriophage Qβ Conjugate as an Anticancer Vaccine

Zahra Rashidijahanabad, Sherif Ramadan, Nicholas A. O'Brien, Athar Nakisa, Shuyao Lang, Howard Crawford, Jeffrey C. Gildersleeve and Xuefei Huang

Angewandte Chemie, 2023, 135
DOI: 10.1002/ange.202309744

Stereoselective Synthesis of Sialyl Lewisa Antigen and the Effective Anticancer Activity of Its Bacteriophage Qβ Conjugate as an Anticancer Vaccine

Zahra Rashidijahanabad, Sherif Ramadan, Nicholas A. O'Brien, Athar Nakisa, Shuyao Lang, Howard Crawford, Jeffrey C. Gildersleeve and Xuefei Huang

Angew Chem Int Ed, 2023, 62
DOI: 10.1002/anie.202309744

NKT Agonist-Antigen Conjugates as Cancer Vaccines

Benjamin J. Compton and Gavin F. Painter

Crit Rev Oncog, 2024, 29, 11
DOI: 10.1615/CritRevOncog.2023049091

A review on biomass-derived levulinic acid for application in drug synthesis

Mingyue Zhang, Nan Wang, Jianguo Liu, Chenguang Wang, Ying Xu and Longlong Ma

Critical Reviews in Biotechnology, 2022, 42, 220
DOI: 10.1080/07388551.2021.1939261

Structural Features of Lipidated and Glycosylated Peptides as Vaccine Adjuvants: Review

Siti Wahyu Sintasari, Nurul Muthia, Fadhilah Anggraini Hidayat, Ace Tatang Hidayat and Rani Maharani

Peptide Science, 2025, 117
DOI: 10.1002/pep2.70007

Middle Molecular and Conjugation Strategies for Development of Bioactive Middle Molecules

Yoshiyuki Manabe, Atushi Shimoyama, Kazuya Kabayama and Koichi Fukase

J. Synth. Org. Chem. Jpn., 2020, 78, 527
DOI: 10.5059/yukigoseikyokaishi.78.527

Intratumoural administration of an NKT cell agonist with CpG promotes NKT cell infiltration associated with an enhanced antitumour response and abscopal effect

Kef K Prasit, Laura Ferrer-Font, Olivia K Burn, Regan J Anderson, Benjamin J Compton, Alfonso J Schmidt, Johannes U Mayer, Chun-Jen J Chen, Nathaniel Dasyam, David S Ritchie, Dale I Godfrey, Stephen R Mattarollo, P Rod Dunbar, Gavin F Painter and Ian F Hermans

OncoImmunology, 2022, 11
DOI: 10.1080/2162402X.2022.2081009

Vaccines Adjuvanted with an NKT Cell Agonist Induce Effective T-cell Responses in Models of CNS Lymphoma

Carole Grasso, Cameron S Field, Ching-Wen Tang, Peter M Ferguson, Benjamin J Compton, Regan J Anderson, Gavin F Painter, Robert Weinkove, Ian F Hermans and Michael V Berridge

Immunotherapy, 2020, 12, 395
DOI: 10.2217/imt-2019-0134

Chemical Strategies to Boost Cancer Vaccines

Wen-Hao Li and Yan-Mei Li

Chem. Rev., 2020, 120, 11420
DOI: 10.1021/acs.chemrev.9b00833

Co-Delivery of the Human NY-ESO-1 Tumor-Associated Antigen and Alpha-GalactosylCeramide by Filamentous Bacteriophages Strongly Enhances the Expansion of Tumor-Specific CD8+ T Cells

Roberta Manco, Luciana D’Apice, Maria Trovato, Lucia Lione, Erika Salvatori, Eleonora Pinto, Mirco Compagnone, Luigi Aurisicchio, Piergiuseppe De Berardinis and Rossella Sartorius

Viruses, 2023, 15, 672
DOI: 10.3390/v15030672

NKT-cell glycolipid agonist as adjuvant in synthetic vaccine

Zheng Liu and Jun Guo

Carbohydrate Research, 2017, 452, 78
DOI: 10.1016/j.carres.2017.10.006

Immunological Evaluation of Co‐Assembling a Lipidated Peptide Antigen and Lipophilic Adjuvants: Self‐Adjuvanting Anti‐Breast‐Cancer Vaccine Candidates

Taku Aiga, Yoshiyuki Manabe, Keita Ito, Tsung‐Che Chang, Kazuya Kabayama, Shino Ohshima, Yoshie Kametani, Ayane Miura, Hiroto Furukawa, Hiroshi Inaba, Kazunori Matsuura and Koichi Fukase

Angewandte Chemie, 2020, 132, 17858
DOI: 10.1002/ange.202007999

Developing an On‐Resin Synthesis of α‐Galactosylceramide‐Peptide Conjugate Vaccines

Michael A. Meijlink, Susanna T. S. Chan, Kathryn J. Farrand, Sarah L. Draper, Oliva K. Burn, Jasmine M. Seifert‐Simpson, Ngarangi C. Mason, Lisa M. Connor, Ian F. Hermans, Gavin F. Painter and Benjamin J. Compton

ChemistryEurope, 2025, 3
DOI: 10.1002/ceur.202400059

Organocatalytic Upgrading of Biomass Derived Building Blocks

Sara Meninno

Eur J Org Chem, 2023, 26
DOI: 10.1002/ejoc.202300264

Glycolipid‐peptide conjugate vaccines elicit CD8+ T‐cell responses and prevent breast cancer metastasis

Olivia K Burn, Kathryn Farrand, Tara Pritchard, Sarah Draper, Ching‐wen Tang, Anna H Mooney, Alfonso J Schmidt, Sung H Yang, Geoffrey M Williams, Margaret A Brimble, Matheswaran Kandasamy, Andrew J Marshall, Kate Clarke, Gavin F Painter, Ian F Hermans and Robert Weinkove

Clin & Trans Imm, 2022, 11
DOI: 10.1002/cti2.1401

Synthesis and Evaluation of Liposomal Anti-GM3 Cancer Vaccine Candidates Covalently and Noncovalently Adjuvanted by αGalCer

Xu-Guang Yin, Jie Lu, Jian Wang, Ru-Yan Zhang, Xi-Feng Wang, Chun-Miao Liao, Xiao-Peng Liu, Zheng Liu and Jun Guo

J. Med. Chem., 2021, 64, 1951
DOI: 10.1021/acs.jmedchem.0c01186

Harnessing NKT cells for vaccination

Olivia K Burn, Theresa E Pankhurst, Gavin F Painter, Lisa M Connor and Ian F Hermans

Oxford Open Immunology, 2021, 2
DOI: 10.1093/oxfimm/iqab013

A Lysosome-Targeted Tetrazine for Organelle-Specific Click-to-Release Chemistry in Antigen Presenting Cells

Nina A.M. Ligthart, Mark A.R. de Geus, Merel A.T. van de Plassche, Diana Torres García, Marjolein M.E. Isendoorn, Luuk Reinalda, Daniëlle Ofman, Tyrza van Leeuwen and Sander I. van Kasteren

J. Am. Chem. Soc., 2023, 145, 12630
DOI: 10.1021/jacs.3c02139

Glycolipid-peptide vaccination induces liver-resident memory CD8 + T cells that protect against rodent malaria

Lauren E. Holz, Yu Cheng Chua, Maria N. de Menezes, Regan J. Anderson, Sarah L. Draper, Benjamin J. Compton, Susanna T. S. Chan, Juby Mathew, Jasmine Li, Lukasz Kedzierski, Zhongfang Wang, Lynette Beattie, Matthias H. Enders, Sonia Ghilas, Rose May, Thiago M. Steiner, Joshua Lange, Daniel Fernandez-Ruiz, Ana Maria Valencia-Hernandez, Taryn L. Osmond, Kathryn J. Farrand, Rebecca Seneviratna, Catarina F. Almeida, Kirsteen M. Tullett, Patrick Bertolino, David G. Bowen, Anton Cozijnsen, Vanessa Mollard, Geoffrey I. McFadden, Irina Caminschi, Mireille H. Lahoud, Katherine Kedzierska, Stephen J. Turner, Dale I. Godfrey, Ian F. Hermans, Gavin F. Painter and William R. Heath

Sci. Immunol., 2020, 5
DOI: 10.1126/sciimmunol.aaz8035

A practical and scalable synthesis of KRN7000 using glycosyl iodide as the glycosyl donor

Yang Zhang, Jia Guo, Xiaoyan Xu, Qi Gao, Xianglai Liu and Ning Ding

Journal of Chemical Research, 2021, 45, 248
DOI: 10.1177/1747519820961018

A Designed α‐GalCer Analog Promotes Considerable Th1 Cytokine Response by Activating the CD1d‐iNKT Axis and CD11b‐Positive Monocytes/Macrophages

Juan Ma, Peng He, Chuanfang Zhao, Quanzhong Ren, Zheng Dong, Jiahuang Qiu, Yang Jing, Sijin Liu and Yuguo Du

Advanced Science, 2020, 7
DOI: 10.1002/advs.202000609

Built-in adjuvants for use in vaccines

Qianqian Li, Zhimei Li, Nan Deng, Feiqing Ding, Yiliang Li and Hui Cai

European Journal of Medicinal Chemistry, 2022, 227, 113917
DOI: 10.1016/j.ejmech.2021.113917

IgG Antibody Response Elicited by a Fully Synthetic Two-Component Carbohydrate-Based Cancer Vaccine Candidate with α-Galactosylceramide as Built-in Adjuvant

Xu-Guang Yin, Xiang-Zhao Chen, Wen-Mei Sun, Xiao-Shan Geng, Xiao-Kang Zhang, Jian Wang, Pan-Pan Ji, Zhong-Yin Zhou, Dong Jae Baek, Guang-Fu Yang, Zheng Liu and Jun Guo

Org. Lett., 2017, 19, 456
DOI: 10.1021/acs.orglett.6b03591

From Immunologically Archaic to Neoteric Glycovaccines

Marco Cavallari and Gennaro De Libero

Vaccines, 2017, 5, 4
DOI: 10.3390/vaccines5010004

α-GalCer and iNKT Cell-Based Cancer Immunotherapy: Realizing the Therapeutic Potentials

Yingting Zhang, Ryan Springfield, Siyang Chen, Xin Li, Xiaotian Feng, Rosa Moshirian, Rirong Yang and Weiming Yuan

Front. Immunol., 2019, 10
DOI: 10.3389/fimmu.2019.01126

Development of Efficiently Quantitative Analysis Targeting α-Galactosylceramide in FreeStyle 293-F Cells

Kentaro Iwata, Koji Nishimura, Kanae Otsutomo, Yasunori Oba and Kei Motonaga

Chem. Pharm. Bull., 2025, 73, 540
DOI: 10.1248/cpb.c25-00161

Immunological Evaluation of Co‐Assembling a Lipidated Peptide Antigen and Lipophilic Adjuvants: Self‐Adjuvanting Anti‐Breast‐Cancer Vaccine Candidates

Taku Aiga, Yoshiyuki Manabe, Keita Ito, Tsung‐Che Chang, Kazuya Kabayama, Shino Ohshima, Yoshie Kametani, Ayane Miura, Hiroto Furukawa, Hiroshi Inaba, Kazunori Matsuura and Koichi Fukase

Angew Chem Int Ed, 2020, 59, 17705
DOI: 10.1002/anie.202007999

A comparison of benzyl and 2-naphthylmethyl ethers as permanent hydroxyl protecting groups in the synthesis of α-galactoglycosphingolipids KRN7000 and PBS-57

Dongming Yao, Yichu Liu, Qi Gao, Qiang Sui, Xiaoping Liu and Ning Ding

Journal of Carbohydrate Chemistry, 2017, 36, 173
DOI: 10.1080/07328303.2017.1375114

iNKT cell agonists as vaccine adjuvants to combat infectious diseases

Ya-Qian Li, Cheng Yan, Rui Luo and Zheng Liu

Carbohydrate Research, 2022, 513, 108527
DOI: 10.1016/j.carres.2022.108527

Programmable Antigen‐Specific Immunity via Self‐Adjuvanting Nanovaccines Co‐Delivering Immune Modulators

Keita Ito, Yoshiyuki Manabe, Shino Ohshima, Masatoshi Maeki, Manabu Tokeshi, Hiroshi Inaba, Kazunori Matsuura, Kazuya Kabayama, Yoshie Kametani and Koichi Fukase

Angewandte Chemie, 2026, 138
DOI: 10.1002/ange.202520474

Peptide-free Synthetic Nicotine Vaccine Candidates with α-Galactosylceramide as Adjuvant

Xiang-Zhao Chen, Ru-Yan Zhang, Xi-Feng Wang, Xu-Guang Yin, Jian Wang, Ya-Cong Wang, Xiu Liu, Jing-Jing Du, Zheng Liu and Jun Guo

Mol. Pharmaceutics, 2019, 16, 1467
DOI: 10.1021/acs.molpharmaceut.8b01095

Antigen/Adjuvant-Displaying Enveloped Viral Replica as a Self-Adjuvanting Anti-Breast-Cancer Vaccine Candidate

Keita Ito, Hiroto Furukawa, Hiroshi Inaba, Shino Ohshima, Yoshie Kametani, Masatoshi Maeki, Manabu Tokeshi, Xuhao Huang, Kazuya Kabayama, Yoshiyuki Manabe, Koichi Fukase and Kazunori Matsuura

J. Am. Chem. Soc., 2023, 145, 15838
DOI: 10.1021/jacs.3c02679

Glycolipid-peptide conjugate vaccines enhance CD8+ T cell responses against human viral proteins

M. Speir, A. Authier-Hall, C. R. Brooks, K. J. Farrand, B. J. Compton, R. J. Anderson, A. Heiser, T. L. Osmond, C. W. Tang, J. A. Berzofsky, M. Terabe, G. F. Painter, I. F. Hermans and R. Weinkove

Sci Rep, 2017, 7
DOI: 10.1038/s41598-017-14690-5

The Adjuvant of α-Galactosylceramide Presented by Gold Nanoparticles Enhances Antitumor Immune Responses of MUC1 Antigen-Based Tumor Vaccines

Yonghui Liu, Zhaoyu Wang, Fan Yu, Mingjing Li, Haomiao Zhu, Kun Wang, Meng Meng and Wei Zhao

IJN, 2021, Volume 16, 403
DOI: 10.2147/IJN.S273883

Preclinical evaluation of therapeutic vaccines for chronic hepatitis B that stimulate antiviral activities of T cells and NKT cells

Anna H. Mooney, Sarah L. Draper, Olivia K. Burn, Regan J. Anderson, Benjamin J. Compton, Chingwen Tang, Kathryn J. Farrand, Pietro Di Lucia, Micol Ravà, Valeria Fumagalli, Leonardo Giustini, Elisa Bono, Dale I. Godfrey, William R. Heath, Weiming Yuan, Francis V. Chisari, Luca G. Guidotti, Matteo Iannacone, John Sidney, Alessandro Sette, Shivali A. Gulab, Gavin F. Painter and Ian F. Hermans

JHEP Reports, 2024, 6, 101038
DOI: 10.1016/j.jhepr.2024.101038

Synthesis and Activity of 6″-Deoxy-6″-thio-α-GalCer and Peptide Conjugates

Benjamin J. Compton, Ching-wen Tang, Karen A. Johnston, Taryn L. Osmond, Colin M. Hayman, David S. Larsen, Ian F. Hermans and Gavin F. Painter

Org. Lett., 2015, 17, 5954
DOI: 10.1021/acs.orglett.5b02836

Engaging Natural Killer T Cells as ‘Universal Helpers’ for Vaccination

Mary Speir, Ian F. Hermans and Robert Weinkove

Drugs, 2017, 77, 1
DOI: 10.1007/s40265-016-0675-z

Carbohydrate-Based Macromolecular Biomaterials

Lu Su, Yingle Feng, Kongchang Wei, Xuyang Xu, Rongying Liu and Guosong Chen

Chem. Rev., 2021, 121, 10950
DOI: 10.1021/acs.chemrev.0c01338

Interleukin-13 peptide vaccine induces protective humoral immunity in murine asthma models

Fengbo Wu, Yan Huang, Peng Zhang, Chunting Wang, Yaomei Tian, Lian Lu, Gu He and Li Yang

Oncotarget, 2018, 9, 6678
DOI: 10.18632/oncotarget.19950

Carbohydrate Conjugates in Vaccine Developments

Shuyao Lang and Xuefei Huang

Front. Chem., 2020, 8
DOI: 10.3389/fchem.2020.00284